CA2597415A1 - Menthane carboxamide derivatives having cooling properties - Google Patents

Menthane carboxamide derivatives having cooling properties Download PDF

Info

Publication number
CA2597415A1
CA2597415A1 CA002597415A CA2597415A CA2597415A1 CA 2597415 A1 CA2597415 A1 CA 2597415A1 CA 002597415 A CA002597415 A CA 002597415A CA 2597415 A CA2597415 A CA 2597415A CA 2597415 A1 CA2597415 A1 CA 2597415A1
Authority
CA
Canada
Prior art keywords
cooling
compounds
compound
menthanecarboxamide
cooling properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002597415A
Other languages
French (fr)
Inventor
Lucienne Cole
Stefan Michael Furrer
Christophe Galopin
Pablo Victor Krawec
Adam Masur
Jay Patrick Slack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2597415A1 publication Critical patent/CA2597415A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/24Thermal properties
    • A61K2800/244Endothermic; Cooling; Cooling sensation

Abstract

A compound of the formula (I) in which X and Y are selected as defined in the description. The compounds have cooling properties and are useful in, for example, foodstuffs , dentifrices and cosmetics .

Description

MENTHANE CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES

This invention relates to heterocyclic compounds having cooling properties.

Cooling compounds, that is, chemical compounds that impart a cooling sensation to the skin or the niucous membranes of the body, are well known to the art and are widely used in a variety of products such as foodstuffs, tobacco products, beverages, dentifrices, mouthwashes and toiletries.

One class of cooling compounds that have enjoyed substantial success consists of N-substituted p-menthane carboxamides. Examples of these compounds are described in, for example, British Patents GB 1,351,761-2 and United States Patent US 4,150,052.

It has now been found that a particular selection of such compounds exhibits a cooling effect that is both surprisingly strong and long-lasting. The invention therefore provides a compound of the formula I

NN
I X I
O ~ Y
in which X and Y are selected as follows:

(i) X is H and Y is selected from the group consisting of O N N
_~N~ ~ o ~
\
N N O
~ a > >
O

and N ; or (ii) X and Y together form a bivalent radical selected from the group consisting of -O-CH2-O-, -N=CH-0- and -N=CH-S- thus forming together with the carbon atoms to which the radical is attached a 5-membered ring (. a 1,3-dioxalane ring, a 1,3-oxazole ring or a 1,3-thiazole ring respectively) Specific examples of compounds of Formula I are shown below:
H
N O H
N S
O
O I
N
N=====\
N N O
O
O

N
O \
O
\
\
N
N H
N

N / O
O y yy \ N
~~
The compounds may be easily prepared and isolated by art-recognized methods They are distinguished from similar compounds of the prior art by their surprisingly high cooling effect (up to 100 times higher than that of similar known compounds) and by the longevity of the cooling effect, which adds to their attractiveness in a large variety of products.

For example, a small group of panelists was asked to taste various solutions of cooling compounds and indicate which solutions had a cooling intensity similar or slightly higher than that of a solution of menthol at 2ppm. Results are shown in table 1.

Table 1 experiment on cooling intensity.
Chemical Concentration 1-Menthol 2.0 ppm N-4-(pyrazol-1-yl)-phenyl-3-p-menthanecarboxamide 0.02 ppm N-4-([1,2,4]triazol-l-yl)-phenyl-3-p-menthanecarboxainide 0.02 ppm N-3-(oxazol-5-yl)-phenyl-3-p-menthanecarboxamide 0.1 ppm N-4-(morpholin-4-yl)-phenyl 3-p-menthanecarboxamide 0.2 ppm N-4-(oxazol-5-yl)-phenyl-3-p-menthanecarboxamide 0.5 ppm N-benzooxazol-4-yl-3-p-menthanecarboxamide 0.02 ppm N-benzo[1,3]dioxol-5-yl-3-p-menthanecarboxamide 0.02 ppm N-benzothiazol-6-yl menthanecarboxamide 0.3 ppm From Table 1, it can be seen that the compounds of Formula I are up to 100 times stronger than menthol, the reference cooling compound. Compounds of Formula I are also much stronger and last longer than WS-3, the best cooling compound of the prior art.

The compounds of the invention may be used in products that are applied to the mouth or the skin to give a cooling sensation. By "applying" is meant any form of bringing into contact, for example, oral ingestion or, in the case of tobacco products, inhalation.
In the case of application to the skin, it may be, for example, by including the compound in a cream or salve, or in a sprayable composition. The invention therefore also provides a method of providing a cooling effect to the mouth or skin by applying tliereto a product comprising a compound as hereinabove described. The invention also provides a composition that provides a cooling sensation to the skin or oral cavity, comprising a compound as hereinabove defined.

The invention is now further described by means of the following non-limiting examples, which describe preferred embodiments.

Example 1 Preparation of N-benzooxazol-4-y13-p-menthanecarboxamide To a flask, were added 0.5 g (3.7 mmol) of benzooxazol-4-ylamine, 0.7 mL of triethylamine and 10 mL of dichloromethane. The mixture is cooled to 0 C and 0.71 g of 3-p-menthanecarboxyl chloride were added dropwise over 5 minutes. The reaction mixture was stirred overnight. To the reaction mixture, 10mL of water were added. The mixture was separated. The aqueous layer is washed with EtOAc (3 x 5rnL). The combined organic layers were washed with 5mL water. The organic layer was dried over Na2SO4. The solvent was evaporated in vacuo to afford the crude product, which was purified over silica gel to afford 0.46 g of the desired product with the following spectroscopic properties:
MS: 300 ([M"]), 133, 97, 83 i H NMR (300 MHz; CDC13) 6: 8.35 (s, 1H), 8.14 (d, 1H), 7.68 (d, 1H), 7.54 (br.
s, 1H), 7.18 (dd, 1H), 2.25 (t, 1H), 1.91 -1.61 (m, 5H), 1.5 -1.23 (m, 2H), 1.17- 0.9 (m, 2H), 0.94 (d, 3H), 0.93 (d, 3H), 0.85 (d, 3H) Example 2 Preparation of N-benzooxazol-6-y13-p-menthanecarboxamide:

A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:
MS: 300 ([M+]), 133, 97, 83 i H NMR (300 MHz; CD3OD) S: 8.33 (s, 1H), 8.02 (m, 2H), 7.23 (dd, 1H), 2.4 (ddd, 1H), 1.88-1.54 (m, 5H), 1.37 (m, IH), 1.0-1.3 (m, 3H), 0.98 (d, 3H), 0.86 (d,3H), 0.82 (d, 3H) Example 3 Preparation of N-benzothiazol-6-yl menthanecarboxamide:

A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:
MS: 316 ([M+]), 150, 97, 83 i H NMR (300 MHz; CD3OD) 8: 9.12 (s,1H), 8.49 (d, 1H), 7.91 (d, 1H), 7.54 (d, 1H), 2.2 (ddd, 1H), 1.88-1.54 (m, 5H), 1.21-1.47 (m, 4H), 0.99 (d, 3H), 0.93 (d, 3H), 0.85 (d, 3H) Example 4 Preparation of N-4-([1,2,4]triazol-1-yl)-phenyl-3-p-menthanecarboxamide A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:
MS: 326 ([M}]), 160, 97, 83 i H NMR (300 MHz; CD3OD) S: 8.98 (s, 1H), 8.07 (s, 1H), 7.84 (s, 4H), 2.26 (t, 1H), 1.9 -1.5 (m, 5H), 1.45 -1.3 (m, 1H), 1.25-1 (m, 3H), 0.94 (d, 3H), 0.86 (d, 3H), 0.8 (d, 3H) Example 5 Preparation of N-4-(oxazol-5-yl)-phenyl-3-p-menthanecarboxamide:

A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:
MS: 326([M+]), 160, 139, 97, 83 i H NMR (300 MHz; CD3OD) S: 8.19 (s, 1H), 7.66 (s, 4H), 7.42 (s, 1H), 2.35 (ddd, 1H), 1.88-1.54 (m, 5H), 1.4-1.35 (m, 1H), 1.0-1.3 (m, 3H), 0.95 (d, 3H), 0.91 (d,3H), 0.84 (d, 3H) Example 6 Preparation of N-3-(oxazol-5-yl)-phenyl-3-p-menthanecarboxamide:

A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:
MS: 326([M+]), 160, 139, 97, 83 Example 7 Application in mouthwash Alcohol 95% 177mL
Sorbito170% 290 g Compound of example 1 as a 1% solution in alcohol lOmL
Peppermint oil, Terpeneless 0.300 g Methyl salicylate 0.640 g Eucalyptol 0.922 g Thymol 0.639 g Benzoic acid 1.500 g Pluronic F127 5.000 g Sodium Saccharin 0.600 g Sodium Citrate 0.300 g Citric Acid 0.100 g Water q.s. 1 liter All the ingredients are mixed. 30 mL of obtained solution is put in the mouth, swished around, gargled and spit out. An intense cooling is felt in every area of the mouth as well as lips. The cooling perception lasts for several hours Example 5 Application in toothpaste Opaque toothgel 98.000 g Compound of example 6 as a 2% solution in PG 1.500g Peppermint oil, Terpeneless 0.500g The chemicals are mixed in the toothgel, a piece of toothgel is put on a toothbrush and a panelist's teeth are brushed. The niouth is rinsed with water and the water is spit out. An intense cooling sensation is felt by the panelist in all areas of the mouth.
The cooling perception lasts for several hours.

Claims (4)

1. A compound of the formula I

in which X and Y are selected as follows:

(i) X is H and Y is selected from the group consisting of or (ii) X and Y together form a bivalent radical selected from the group consisting of -O-CH2-O-, N=CH-O- and N=CH-S- thus forming together with the carbon atoms to which the radical is attached a 5-membered ring.
2. A method of providing a cooling effect to the mouth or skin by applying thereto a product comprising a compound according to claim 1.
3. A composition that provides a cooling sensation to the skin or oral cavity, comprising a compound according to claim 1.
4. A compound of formula I, selected from the group consisting of
CA002597415A 2005-03-01 2006-02-23 Menthane carboxamide derivatives having cooling properties Abandoned CA2597415A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65756205P 2005-03-01 2005-03-01
US60/657,562 2005-03-01
PCT/CH2006/000116 WO2006092074A1 (en) 2005-03-01 2006-02-23 Menthane carboxamide derivatives having cooling properties

Publications (1)

Publication Number Publication Date
CA2597415A1 true CA2597415A1 (en) 2006-09-08

Family

ID=36127379

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002597415A Abandoned CA2597415A1 (en) 2005-03-01 2006-02-23 Menthane carboxamide derivatives having cooling properties

Country Status (12)

Country Link
US (1) US7868004B2 (en)
EP (1) EP1853565B1 (en)
JP (1) JP2008531606A (en)
KR (1) KR20070107083A (en)
CN (1) CN101133030B (en)
AT (1) ATE482199T1 (en)
BR (1) BRPI0607407A2 (en)
CA (1) CA2597415A1 (en)
DE (1) DE602006017038D1 (en)
ES (1) ES2352563T3 (en)
MX (1) MX2007010040A (en)
WO (1) WO2006092074A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2342466T7 (en) 2003-11-21 2012-11-19 Givaudan Sa P-MENTANOCARBOXAMIDS N-SUBSTITUTED.
US8263046B2 (en) 2005-10-25 2012-09-11 Givaudan S.A. N-phenyl-N-pyridinyl-benzamides and benzenesulfonomides having cooling properties
WO2008075942A1 (en) * 2006-12-20 2008-06-26 Givaudan Nederland Services B.V. N-substituted-p-menthane-3-carboxamide and uses thereof
WO2009076792A1 (en) * 2007-12-19 2009-06-25 Givaudan Sa Cooling compounds
WO2009089641A1 (en) * 2008-01-17 2009-07-23 Givaudan Sa Benzimidazole derivatives and their use as cooling agents
GB0902849D0 (en) * 2009-02-19 2009-04-08 Givaudan Sa Organic compounds
GB201103103D0 (en) 2011-02-23 2011-04-06 Givaudan Sa Organic compounds
EP2497458A1 (en) 2011-03-08 2012-09-12 B.R.A.I.N. Biotechnology Research And Information Network AG Small molecule modulators of the cold and menthol receptor TRPM8
CN106458861B (en) 2014-04-23 2020-05-19 宝洁公司 Cyclopropanecarboxamides having cooling properties

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1351761A (en) * 1971-02-04 1974-05-01 Wilkinson Sword Ltd Substituted p-menthane carboxamides and compositions containing them
US5918309A (en) * 1997-10-14 1999-07-06 Second Chance Body Armor, Inc. Blunt force resistant structure for a protective garment
AU2003271498A1 (en) * 2002-10-28 2004-05-13 Givaudan Sa Coolant solutions and compositions comprising the sameitle
CN102389409B (en) 2003-07-02 2014-01-22 健泰科生物技术公司 TRP-P8 active compounds and therapeutic treatment methods
CA2535265C (en) 2003-08-22 2014-01-28 Dendreon Corporation Compositions and methods for the treatment of disease associated with trp-p8 expression
ES2342466T7 (en) * 2003-11-21 2012-11-19 Givaudan Sa P-MENTANOCARBOXAMIDS N-SUBSTITUTED.
GB0425661D0 (en) 2004-11-23 2004-12-22 Givaudan Sa Organic compounds
US8673198B2 (en) * 2006-02-18 2014-03-18 Honeywell International Inc Method of making improved ballistic products

Also Published As

Publication number Publication date
EP1853565A1 (en) 2007-11-14
ATE482199T1 (en) 2010-10-15
MX2007010040A (en) 2007-09-21
DE602006017038D1 (en) 2010-11-04
JP2008531606A (en) 2008-08-14
US20080305051A1 (en) 2008-12-11
ES2352563T3 (en) 2011-02-21
CN101133030B (en) 2010-07-28
WO2006092074A1 (en) 2006-09-08
KR20070107083A (en) 2007-11-06
CN101133030A (en) 2008-02-27
BRPI0607407A2 (en) 2009-09-01
US7868004B2 (en) 2011-01-11
EP1853565B1 (en) 2010-09-22

Similar Documents

Publication Publication Date Title
EP1685093B1 (en) N-substituted p-menthane carbosamided
US11059783B2 (en) Pyridinyl cyclohexanecarboxamide cooling compounds
EP1853565B1 (en) Menthane carboxamide derivatives having cooling properties
US20080319055A1 (en) Cooling Compounds
US7893110B2 (en) Carboxylic acid amides provoking a cooling sensation
US20080112899A1 (en) Carboxamides and Their Use
US8377422B2 (en) Carboxamide derivatives having cooling properties
WO2008141469A2 (en) Butone derivatives useful as cooling agents
US20090035364A1 (en) Para-substituted 2-alkoxyphenol compounds
US20100297038A1 (en) Benzimidazole Derivatives And Their Use As Cooling Agents

Legal Events

Date Code Title Description
FZDE Discontinued